First Patient Treated with Proton Therapy at Lynn Cancer Institute
-
May 15, 2026
-
5 min
May 15, 2026
Nadine Abi-Jaoudeh, MD shared promising Phase 1 data at ASCO 2026 regarding a novel interventional approach for locally advanced pancreatic cancer.
June 22, 2026
Harold Burstein, MD, PhD, and Erica Mayer, MD, MPH discuss results from the SERENA-6 trial, which were presented at the 2026 ESMO Breast Cancer Congress.
June 26, 2026
Dana-Farber Cancer Institute's Dr. Sara Tolaney presented a subgroup analysis of the ASCENT-04 study based on biomarkers. Across all subgroups, patients who received sacituzumab govitecan plus pembro as first-line therapy had longer progression-free survival compared to standard therapy.
July 1, 2026